Approximately 29% of Infants Receive RSV Immunization in the 2023-2024 Season
In the 2023-2024 season, nearly 30% of infants in the U.S. received RSV protection via vaccination or monoclonal antibodies, highlighting ongoing efforts to combat severe respiratory infections in newborns.
During the 2023-2024 respiratory virus season, about 29% of infants born between October 2023 and March 2024 in 33 U.S. states and the District of Columbia were immunized against respiratory syncytial virus (RSV). This coverage includes vaccinations administered through infant receipt of nirsevimab and maternal RSV vaccination during pregnancy. Researchers from the CDC, led by Ellen O. Boundy, estimated that 19% of infants received nirsevimab, a monoclonal antibody, while 10% were vaccinated maternally. Notably, 38% of infants given nirsevimab received it within the first week of life. The variation in immunization coverage among states ranged from 11% to 53%. These efforts aim to enhance protection for infants against severe RSV disease, although experts emphasize the need for increased immunization initiatives to better safeguard this vulnerable population.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Enhancing Rural School Attendance Through On-Site Health Clinics
A recent study demonstrates that on-site health clinics in rural schools significantly reduce student absenteeism, improving educational and health outcomes in underserved communities.
Study Uncovers Attitudes of Ohio Primary Care Providers Toward Treatment of Diabetes and Opioid Use Disorder
Research reveals primary care providers in Ohio are more empathetic toward patients with opioid use disorder but are less likely to treat it themselves, highlighting stigma and organizational barriers. Expanding addiction care in primary care settings is crucial to addressing Ohio's opioid epidemic.
RNA Isoform Atlas Enhances Understanding of Cardiovascular Disease
A new RNA isoform atlas developed by Northwestern scientists provides critical insights into gene splicing variations in healthy and diseased hearts, paving the way for improved cardiovascular disease diagnosis and treatment.